Page last updated: 2024-10-23

benserazide and Sleep Apnea Syndromes

benserazide has been researched along with Sleep Apnea Syndromes in 2 studies

Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.

Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.

Research Excerpts

ExcerptRelevanceReference
"Improving sleep quality in patients with obstructive sleep apnea (OSA) by positive airway pressure therapy is associated with a decrease of blood pressure (BP)."1.72The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea. ( Babel, N; Bertram, S; Büchner, N; Doevelaar, A; Mühlberger, D; Racovitan, D; Rohn, B; Seibert, FS; Seidel, M; Toma, D; Wang, S; Westhoff, TH, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Toma, D1
Bertram, S1
Racovitan, D1
Seidel, M1
Doevelaar, A1
Seibert, FS1
Rohn, B1
Babel, N1
Mühlberger, D1
Büchner, N1
Wang, S1
Westhoff, TH1
Yoshida, T1
Kono, I1
Yoshikawa, K1
Hashimoto, H1
Harada, H1
Nakagawa, M1

Other Studies

2 other studies available for benserazide and Sleep Apnea Syndromes

ArticleYear
The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea.
    Scientific reports, 2022, 03-07, Volume: 12, Issue:1

    Topics: Aged; Benserazide; Blood Pressure; Dopamine Agonists; Humans; Levodopa; Middle Aged; Restless Legs S

2022
Improvement of sleep hypopnea by antiparkinsonian drugs in a patient with Parkinson's disease: a polysomnographic study.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:11

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Cabergoline; Ergolines; Humans; Levodopa

2003